Prostate Cancer
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer - Abstract
October 9, 2013
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer - Abstract
October 9, 2013
A new era of testosterone and prostate cancer: From physiology to clinical implications - Abstract
October 9, 2013
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance - Abstract
October 9, 2013
The use of an active appearance model for automated prostate segmentation in magnetic resonance - Abstract
October 8, 2013
Ten-year outcomes of sexual function after radical prostatectomy: Results of a prospective longitudinal study - Abstract
October 8, 2013
Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer - Abstract
October 8, 2013